In last trading session, Phio Pharmaceuticals Corp (NASDAQ:PHIO) saw 5.99 million shares changing hands with its beta currently measuring 1.45. Company’s recent per share price level of $1.74 trading at -$0.77 or -30.68% at ring of the bell on the day assigns it a market valuation of $1.84M. That closing price of PHIO’s stock is at a discount of -494.83% from its 52-week high price of $10.35 and is indicating a discount of -24.71% from its 52-week low price of $2.17. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 31560.0 shares which gives us an average trading volume of 64.41K if we extend that period to 3-months.

Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information

Upright in the red during last session for losing -30.68%, in the last five days PHIO remained trading in the red while hitting it’s week-highest on Thursday, 12/19/24 when the stock touched $1.74 price level, adding 42.0% to its value on the day. Phio Pharmaceuticals Corp’s shares saw a change of -74.56% in year-to-date performance and have moved -39.40% in past 5-day. Phio Pharmaceuticals Corp (NASDAQ:PHIO) showed a performance of -31.82% in past 30-days. Number of shares sold short was 51491.0 shares which calculate 0.5 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 62.38% during past 5 years.

Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders

Insiders are in possession of 4.81% of company’s total shares while institution are holding 3.02 percent of that, with stock having share float percentage of 3.17%. Investors also watch the number of corporate investors in a company very closely, which is 3.02% institutions for Phio Pharmaceuticals Corp that are currently holding shares of the company.